Volume 14, Issue 2 (2-2026)                   JoMMID 2026, 14(2): 108-114 | Back to browse issues page

Ethics code: R/2024/04

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Elumalai A, Darique A. Mycological Profile of Onychomycosis: A Four-Year Retrospective Analysis from a Tertiary Care Center in South India. JoMMID 2026; 14 (2) :108-114
URL: http://jommid.pasteur.ac.ir/article-1-746-en.html
Mycological Profile of Onychomycosis: A Four-Year Retrospective Analysis from a Tertiary Care Center in South India
Arthi Elumalai * , Ashitha Darique
Department of Microbiology, Pondicherry Institute of Medical Sciences, Puducherry, India
Abstract:   (845 Views)
Introduction: Onychomycosis (OM) is the most common nail disorder, accounting for up to 50% of nail dystrophies. The global prevalence of OM is 5.5%, and India has a reported prevalence ranging from 0.5% to 5% across different regions. The most common agents of OM are dermatophytes, particularly Trichophyton rubrum and Trichophyton interdigitale. However, Indian literature shows considerable variability in the clinical presentations and the etiological spectrum. This study was conducted to determine the clinical presentations and mycological profile of OM in a tertiary care setting in South India. Methods: This retrospective descriptive study, conducted over a 4-year period, reviewed records of patients attending the dermatology clinic with a clinical suspicion of OM from January 2020 to December 2023. Nail samples were processed using standard microscopic and culture methods. Results: Of the 172 patients with clinically suspected OM included in the study, 78 (45.3%) were laboratory-confirmed by potassium hydroxide (KOH) microscopy and/or fungal culture. Females predominated, with a male-to-female ratio of 1:1.8. Fingernails were the most commonly affected site, with fingernail involvement observed in 55.8% of the clinically suspected cases. Distal lateral subungual onychomycosis (DLSO) was the predominant clinical presentation, accounting for 55.8% of the clinically suspected cases. Among the fungal isolates, Candida spp. were the most frequently isolated (54.7% of the 64 culture-positive isolates), followed by Fusarium spp. (25.0%). Dermatophytes were isolated in only 3.1% of the culture-positive isolates (n = 2, both identified as T. rubrum). Conclusion: This study demonstrates predominance of non-dermatophyte molds (NDMs) and Candida spp. over dermatophytes among culture-positive isolates in our specific tertiary care setting, which contrasts with several earlier Indian studies that reported dermatophyte predominance. These findings suggest that NDMs and Candida spp. may be important fungal isolates in OM in similar settings, although their pathogenic significance, particularly for NDMs and yeasts, requires careful clinical and laboratory correlation.
 
Keywords: Onychomycosis, Candida, Non-dermatophyte molds, India, Fusarium
Full-Text [PDF 977 kb]   (72 Downloads)    
Type of Study: Original article | Subject: Epidemiologic studies including microbial genotyping, phenotyping and serotyping
Received: 2025/07/8 | Accepted: 2026/02/21 | Published: 2026/09/7
References
1. Hoy NY, Leung AK, Metelitsa AI, Adams S. New concepts in median nail dystrophy, onychomycosis, and hand, foot, and mouth disease nail pathology. Int Sch Res Notices. 2012; 680163. [DOI:10.5402/2012/680163] [PMID] [PMCID]
2. Vlahovic TC. Onychomycosis: Evaluation, treatment options, managing recurrence, and patient outcomes. Clin Podiatr Med Surg. 2016; 33 (3): 305-18. [DOI:10.1016/j.cpm.2016.02.001] [PMID]
3. Gupta AK, Versteeg SG, Shear NH. Confirmatory testing prior to initiating onychomycosis therapy is cost-effective. J Cutan Med Surg. 2018; 22 (2): 129-41. [DOI:10.1177/1203475417733461] [PMID]
4. Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V. Update on current approaches to diagnosis and treatment of onychomycosis. Expert Rev Anti Infect Ther. 2018; 16 (12): 929-38. [DOI:10.1080/14787210.2018.1544891] [PMID]
5. Murray SC, Dawber RP. Onychomycosis of toenails: Orthopaedic and podiatric considerations. Australas J Dermatol. 2002; 43: 105-12. [DOI:10.1046/j.1440-0960.2002.t01-1-00570.x] [PMID]
6. Gupta AK, Venkataraman M, Quinlan EM. Onychomycosis in the twenty-first century: an update on epidemiology and diagnosis. In: Bouchara JP Nenoff P, Gupta AK, Chaturvedi V, editors. Dermatophytes and dermatophytoses. Cham: Springer; 2021. [DOI:10.1007/978-3-030-67421-2_3]
7. Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B, Leung AAM, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020; 14 (1): 32-45. [DOI:10.2174/1872213X13666191026090713] [PMID] [PMCID]
8. Daggett C, Brodell RT, Daniel CR, Jackson J. Onychomycosis in athletes. Am J Clin Dermatol. 2019; 20 (5): 691-8. [DOI:10.1007/s40257-019-00448-4] [PMID]
9. Bramono K, Budimulja U. Epidemiology of onychomycosis in Indonesia: data obtained from three individual studies. Nihon Ishinkin Gakkai Zasshi. 2005; 46: 171-6. [DOI:10.3314/jjmm.46.171] [PMID]
10. Bodman MA, Syed HA, Krishnamurthy K. Onychomycosis. [updated 2025 Nov 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441853/
11. Petrucelli MF, Abreu MH, Cantelli BAM, Segura GG, Nishimura FG, Bitencourt TA, et al. Epidemiology and diagnostic perspectives of dermatophytoses. J Fungi (Basel). 2020; 6 (4): 310. [DOI:10.3390/jof6040310] [PMID] [PMCID]
12. Kaur R, Kashyap B, Bhalla P. A five-year survey of onychomycosis in New Delhi, India: epidemiological and laboratory aspects. Indian J Dermatol. 2007; 52 (1): 39-42. [DOI:10.4103/0019-5154.31923]
13. Yadav P, Singal A, Pandhi D, Das S. Clinico-mycological study of dermatophyte toenail onychomycosis in New Delhi, India. Indian J Dermatol Venereol Leprol. 2015; 81 (3): 293-6. [DOI:10.4103/0019-5154.152511] [PMID] [PMCID]
14. Chetana K, Menon R, David BG, Ramya MR. Clinicomycological and histopathological profile of onychomycosis: a cross-sectional study from South India. Indian J Dermatol. 2019; 64 (4): 272-6. [DOI:10.4103/ijd.IJD_160_18] [PMID] [PMCID]
15. Chanyachailert P, Leeyaphan C, Bunyaratavej S. Cutaneous fungal infections caused by dermatophytes and non-dermatophytes: an updated comprehensive review of epidemiology, clinical presentations, and diagnostic testing. J Fungi. 2023; 9 (6): 669. [DOI:10.3390/jof9060669] [PMID] [PMCID]
16. Agrawal S, Singal A, Grover C, Das S, Madhu SV. Clinico-mycological study of onychomycosis in Indian diabetic patients. Indian Dermatol Online J. 2023; 14 (6): 807-13. [DOI:10.4103/idoj.idoj_642_22] [PMID] [PMCID]
17. Borgohain P, Barua P, Shaw D, Saikia LR, Mahanta J, Rudramurthy SM. Onychomycosis caused by dematiaceous fungi: A four-year study on agricultural workers of Assam, India. Curr Med Mycol. 2023; 9 (3): 8-15.
18. Shemer A, Davidovici B, Grunwald MH, Trau H, Amichai B. New criteria for the laboratory diagnosis of nondermatophyte moulds in onychomycosis. Br J Dermatol. 2009; 160 (1): 37-9. [DOI:10.1111/j.1365-2133.2008.08805.x] [PMID]
19. Rosen T, Friedlander SF, Kircik L, Zirwas MJ, Stein Gold L, Bhatia N, et al. Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape. J Drugs Dermatol. 2015; 14 (3): 223-33.
20. Bermudez NM, Rodríguez-Tamez G, Perez S, Tosti A. Onychomycosis: old and new. J Fungi. 2023; 9 (5): 559. [DOI:10.3390/jof9050559] [PMID] [PMCID]
21. Kumwenda P, Cottier F, Hendry AC, Kneafsey D, Keevan B, Gallagher H, et al. Estrogen promotes innate immune evasion of Candida albicans through inactivation of the alternative complement system. Cell Rep. 2022; 38 (1): 110183. [DOI:10.1016/j.celrep.2021.110183] [PMID]
22. Sangeetha AD, Gopalakrishnan K, Ramachandran R, Narasimhan M, Ramraj B. A descriptive study of onychoscopic features in various subtypes of onychomycosis. Med J Armed Forces India. 2022; 78 (Suppl): S219-25. [DOI:10.1016/j.mjafi.2021.03.019] [PMID] [PMCID]
23. Kayarkatte MN, Singal A, Pandhi D, Das S. Clinico-mycological study of onychomycosis in a tertiary care hospital-a cross-sectional study. Mycoses. 2020; 63 (1): 113-8.. [DOI:10.1111/myc.13025] [PMID]
24. Cohen JL, Scher RK, Pappert AS, Elewski BE. The nail and fungal infections. In: Scher RK, Elewski BE, editors. Cutaneous fungal infections. New York: Igaku-Shoin; 1992. p. 106-122.
25. Rather S, Keen A, Shah FY, Yaseen A, Farooq S, Bakhshi A. Candidal onychomycosis: clinicoepidemiological profile, prevailing strains, and antifungal susceptibility pattern: a study from a tertiary care hospital. Indian J Dermatol. 2021; 66 (2): 132-7. [DOI:10.4103/ijd.IJD_395_20] [PMID] [PMCID]
26. Gelotar P, Vachhani S, Patel B, Makwana N. The prevalence of fungi in fingernail onychomycosis. J Clin Diagn Res. 2013; 7 (2): 250-2 [DOI:10.7860/JCDR/2013/5257.2739] [PMID] [PMCID]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.